Unit-Dose Radiopharmaceutical Supply (Bone & General Imaging)

The contract is for the supply of Tc-99m MDP and Tc-99m Sestamibi radiopharmaceuticals used in bone scans and general nuclear imaging procedures, issued as a subcontract under the Defense Health Agency, part of the Department of Defense. The procurement is targeted for performance in Portsmouth and is classified under NAICS code 325412, which pertains to pharmaceutical and medicinal chemical manufacturing. The opportunity was posted on June 29, 2026, with a firm response deadline of July 19, 2026, at 9:00 PM Eastern Time. Although no set-aside designation or specific point of contact is provided, the requirement emphasizes consistent, reliable delivery of these critical diagnostic agents to support military and veteran healthcare imaging needs. All submissions must comply with federal procurement standards and meet the technical and regulatory requirements for radiopharmaceutical production and distribution.